SCHEMBL112466

SCHEMBL112466

Oc1c(Cl)cc(I)c2cccnc12

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.76
HSP90AA1 P07900 7/20 0.76
MEN1 O00255 6/20 0.76
HTT P42858 6/20 0.76
KMT2A Q03164 6/20 0.76
SMN1; SMN2 Q16637 6/20 0.76
TDP1 Q9NUW8 6/20 0.76
LMNA P02545 5/20 0.76
MAPT P10636 5/20 0.76
ALDH1A1 P00352 4/20 0.76
TP53 P04637 4/20 0.76
ALOX15 P16050 3/20 0.76
SLC6A2 P23975 3/20 0.76
OPRK1 P41145 3/20 0.76
MMP14 P50281 3/20 0.76
USP2 O75604 3/20 0.76
CYP3A4 P08684 2/20 0.76
HPGD P15428 2/20 0.76
ALOX12 P18054 2/20 0.76
MAPK1 P28482 2/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chloroxine SCHEMBL29157288 0.89 KDM4E (0.80) KDM4EHSP90AA1MEN1HTTKMT2A
Clioquinol SCHEMBL11749381 0.86 KDM4E (1.00) KDM4EHSP90AA1MEN1HTTKMT2A
Clioquinol SCHEMBL29370380 0.86 KDM4E (1.00) KDM4EHSP90AA1MEN1HTTKMT2A
Clioquinol SCHEMBL3967 0.86 KDM4E (1.00) KDM4EHSP90AA1MEN1HTTKMT2A
Clioquinol SCHEMBL30592904 0.86 KDM4E (1.00) KDM4EHSP90AA1MEN1HTTKMT2A
Clioquinol SCHEMBL28531298 0.85 KDM4E (0.97) KDM4EHSP90AA1MEN1HTTKMT2A
Clioquinol SCHEMBL28529781 0.85 KDM4E (0.97) KDM4EHSP90AA1MEN1HTTKMT2A
Clioquinol SCHEMBL28524321 0.85 KDM4E (0.97) KDM4EHSP90AA1MEN1HTTKMT2A
Clioquinol SCHEMBL18985133 0.85 KDM4E (0.97) KDM4EHSP90AA1MEN1HTTKMT2A
Clioquinol SCHEMBL28198183 0.85 KDM4E (0.97) KDM4EHSP90AA1MEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10729630-B2 Shaping keratin fibres using an active agent comprising at least two functional groups selected from: —C(OH)- and —C(=O)OH THE PROCTER & GAMBLE COMPANY (US) 2020-08-04 US claimed
CN-105828786-B Shaping keratin fibres using AN AN active agent comprising a functional group selected from-C (═ O) -, -C (═ O) -H and-C (═ O) -O-) 宝洁公司 2020-07-07 CN claimed
EP-3082494-B1 METHOD FOR SHAPING FIBROUS MATERIAL PROCTER & GAMBLE (US) 2018-12-05 EP claimed
EP-3082746-B1 SHAPING KERATIN FIBRES USING AN AMINE OR A DIAMINE PROCTER & GAMBLE (US) 2018-11-28 EP claimed
EP-3082736-B1 SHAPING KERATIN FIBRES USING 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID AND/OR 1,2,3,4-BUTANETETRACARBOXYLIC ACID PROCTER & GAMBLE (US) 2018-08-08 EP claimed
EP-3082747-B1 SHAPING KERATIN FIBRES USING A SUGAR PROCTER & GAMBLE (US) 2018-07-04 EP claimed
EP-3082731-B1 SHAPING KERATIN FIBRES USING AN ACTIVE AGENT COMPRISING AT LEAST TWO FUNCTIONAL GROUPS SELECTED FROM: -C(OH)- AND -C(=O)OH PROCTER & GAMBLE (US) 2018-07-04 EP claimed
EP-3082735-B1 SHAPING KERATIN FIBRES USING OXOETHANOIC ACID AND/OR DERIVATIVES THEREOF PROCTER & GAMBLE (US) 2018-05-02 EP claimed
US-9918921-B2 Methods for shaping fibrous material and treatment compositions therefor THE PROCTER & GAMBLE COMPANY (US) 2018-03-20 US claimed
US-9877559-B2 Methods for shaping fibrous material and treatment compositions therefor THE PROCTER & GAMBLE COMANY (US) 2018-01-30 US claimed
WO-2015094837-A1 SHAPING KERATIN FIBRES USING CARBONATE ESTER THE PROCTER & GAMBLE COMPANY (US) 2015-06-25 WO claimed
WO-2015094758-A1 SHAPING KERATIN FIBRES USING AN ACTIVE AGENT COMPRISING A FUNCTIONAL GROUP SELECTED FROM THE GROUP CONSISTING OF: -C(=O)-, -C(=O)-H, AND -C(=O)-O- THE PROCTER & GAMBLE COMPANY (US) 2015-06-25 WO claimed
WO-2015094784-A1 METHODS FOR SHAPING FIBROUS MATERIAL AND TREATMENT COMPOSITIONS THEREFOR THE PROCTER & GAMBLE COMPANY (US) 2015-06-25 WO claimed
WO-2015094757-A1 SHAPING KERATIN FIBRES USING A SUGAR THE PROCTER & GAMBLE COMPANY (US) 2015-06-25 WO claimed
WO-2015094788-A1 METHODS FOR SHAPING FIBROUS MATERIAL AND TREATMENT COMPOSITIONS THEREFOR THE PROCTER & GAMBLE COMPANY (US) 2015-06-25 WO claimed
WO-2015094759-A1 SHAPING KERATIN FIBRES USING AN ACTIVE AGENT COMPRISING AT LEAST TWO FUNCTIONAL GROUPS SELECTED FROM: -C(OH)- AND -C(=O)OH THE PROCTER & GAMBLE COMPANY (US) 2015-06-25 WO claimed
US-20150173478-A1 Methods for Shaping Fibrous Material and Treatment Compositions Therefor THE PROCTER & GAMBLE COMPANY 2015-06-25 US claimed
WO-2015094789-A1 METHODS FOR SHAPING FIBROUS MATERIAL AND TREATMENT COMPOSITIONS THEREFOR THE PROCTER & GAMBLE COMPANY (US) 2015-06-25 WO claimed
WO-2015094756-A1 SHAPING KERATIN FIBRES USING AN AMINE OR A DIAMINE THE PROCTER & GAMBLE COMPANY (US) 2015-06-25 WO claimed
WO-2009140215-A2 METHOD FOR TREATING DRUG-RESISTANT BACTERIAL AND OTHER INFECTIONS WITH CLIOQUINOL, PHANQUINONE, AND RELATED COMPOUNDS GERAGHTY, ERIN (US) 2009-11-19 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10729630-B2 Shaping keratin fibres using an active agent comprising at least two functional groups selected from: —C(OH)- and —C(=O)OH KRT18, CKAP4, JUP KDM4E 181/4885HSP90AA1 1021/4885MEN1 2788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.